Therapy

Therapies that support recovery after neurological injury and illness.

  • Can exercise and rehab services be integrated into breast cancer care?
    Therapy28 Apr

    A new trial has revealed the potential of a programme designed to connect patients who have breast cancer to needed exercise and rehabilitation services starting at diagnosis and throughout care. Exercise services for individuals with breast cancer can improve functional deficits, fitness, and strength. Rehabilitation services treat neurological and musculoskeletal deficits, such as impaired shoulder [...]

  • Gene replacement therapy for spinal muscular atrophy shows positive trial results
    Therapy25 Mar

    A Phase 3 trial of intrathecal onasemnogene abeparvovec (OAV101 IT) - an investigational gene replacement therapy - in children ages two to 18 years with spinal muscular atrophy (SMA) has shown positive results. OAV101 IT is designed to directly address the genetic root cause of the disease by replacing the nonworking SMN1 gene with a [...]

  • Parakeet study could inform development of new speech therapies
    Therapy21 Mar

    A new study investigating how a parakeet’s brain helps it to mimic human words has established the bird as an important animal model for investigating speech motor control, and researchers say the findings could help develop therapeutic solutions for addressing a range of communication disorders. By recording for the first time the brain activity of [...]

  • Fourier Rehab announces GReAT 2025 summit
    Therapy5 Mar

    Fourier Rehab is set to host GReAT 2025, a premier global summit bringing together experts, innovators, and thought leaders in rehabilitation technology. Taking place at the Fourier Shanghai Headquarters from April 23-24, 2025, this exclusive event will provide insights into the latest advancements in assistive technology and rehabilitation solutions. Since its inception in 2020, the [...]

  • Improved brain decoder holds promise for communication in people with aphasia
    Stroke7 Feb

    A pair of researchers at The University of Texas at Austin have demonstrated an AI-based tool that can translate a person’s thoughts into continuous text, without requiring the person to comprehend spoken words. And the process of training the tool on a person’s own unique patterns of brain activity only takes about an hour. This [...]

  • The power of personal goals in the rehabilitation journey
    Therapy5 Feb

    By Victoria Sudworth, Clinical Commissioning Support Manager at The Daley Care Centre In rehabilitation, the importance of setting personal goals cannot be overstated. These goals shape the trajectory of an individual's recovery and provide a crucial sense of direction.   Rather than a one-size-fits-all approach, rehabilitation is most effective when tailored to the [...]

  • NR Times rehab tech roundup
    Therapy4 Feb

    We round up the latest innovations in rehab tech, from falls detection in care homes to deep brain stimulation for Parkinson's BrainSense adaptive deep brain stimulation tech personalises Parkinson's therapy For 30 years, people with Parkinson's disease have benefitted from deep brain stimulation (DBS), a technology that transmits electric signals to the brain to disrupt [...]

  • How speech and language therapy transformed a patient’s journey to connection and recovery
    Speech & language therapy27 Jan

    In the following article, written by Ellice Wood, Highly Specialist Speech and Language Therapist at St Andrew’s Healthcare, Ellice discusses how building understanding, empathy and emotional resilience can break down barriers in communication, demonstrating the profound impact of Speech and Language Therapy on mental health and social integration. In mental healthcare, the importance of Speech [...]

  • J&J expands neurological drug portfolio with $14.6bn Intra-Cellular Therapies acquisition
    Dementia13 Jan

    Johnson & Johnson (J&J) has confirmed it has acquired neurological drug developer Intra-Cellular Therapies in a US$14.6bn deal. The deal will see J&J strengthen is neurological drug portfolio with Intra-Cellular's central nervous system disorder therapeutics for conditions such as Alzheimer's Disease, bipolar disorder and major depressive disorder. This includes CAPLYTA (lumateperone), which is an approved [...]

  • Aphasia research paves the way for more tailored treatments
    Stroke13 Jan

    A new study from a team of international researchers has revealed why people with aphasia have difficulty talking about past and future events. The findings could lead to the development of more comprehensive diagnositic techniques. Aphasia is a severe speech disorder, often resulting from a stroke, in which individuals lose the ability to speak coherently. [...]